Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93574692 | 9357469 | 2 | F | 20130530 | 20160823 | 20130620 | 20160930 | EXP | US-ROCHE-1239048 | ROCHE | 71.00 | YR | F | Y | 85.45000 | KG | 20160930 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 93574692 | 9357469 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | OVER 30-90 MINUTES ON DAY 1 (STARTING WITH CYCLE 2 FOR THOSE PTS ENTERING POST SURGERY) X 6 CYCLES, | N | 125085 | 15 | MG/KG | SOLUTION FOR INFUSION | ||||||
| 93574692 | 9357469 | 2 | SS | Bevacizumab | BEVACIZUMAB | 1 | Intravenous (not otherwise specified) | N | 125085 | ||||||||||
| 93574692 | 9357469 | 3 | SS | PACLITAXEL. | PACLITAXEL | 1 | Intravenous (not otherwise specified) | LAST DOSE PRIOR TO SAE: 01/NOV/2011 | N | 0 | 175 | MG/M**2 | |||||||
| 93574692 | 9357469 | 4 | SS | CARBOPLATIN. | CARBOPLATIN | 1 | Intravenous (not otherwise specified) | AUC = 6 OVER 30 MINUTES ON DAY 1 X 6 CYCLES, LAST DOSE PRIOR TO SAE: 01/NOV/2011 | N | 0 | |||||||||
| 93574692 | 9357469 | 5 | SS | IXABEPILONE | IXABEPILONE | 1 | Unknown | N | 0 | ||||||||||
| 93574692 | 9357469 | 6 | SS | TEMSIROLIMUS | TEMSIROLIMUS | 1 | Unknown | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 93574692 | 9357469 | 1 | Endometrial cancer |
| 93574692 | 9357469 | 3 | Endometrial cancer |
| 93574692 | 9357469 | 4 | Endometrial cancer |
| 93574692 | 9357469 | 5 | Endometrial cancer |
| 93574692 | 9357469 | 6 | Endometrial cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 93574692 | 9357469 | HO |
| 93574692 | 9357469 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 93574692 | 9357469 | Bone pain | |
| 93574692 | 9357469 | Cerebral ischaemia | |
| 93574692 | 9357469 | Cerebrovascular accident | |
| 93574692 | 9357469 | Cystitis | |
| 93574692 | 9357469 | Myalgia | |
| 93574692 | 9357469 | Neutrophil count decreased | |
| 93574692 | 9357469 | Platelet count decreased | |
| 93574692 | 9357469 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 93574692 | 9357469 | 1 | 20110712 | 20130604 | 0 | |
| 93574692 | 9357469 | 2 | 20110802 | 0 | ||
| 93574692 | 9357469 | 3 | 20110712 | 20130604 | 0 | |
| 93574692 | 9357469 | 4 | 20110712 | 20130604 | 0 |